Seattle Genetics reported $3.62B in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Abbvie ABBV:US $ 143211M 3318M
Acadia Pharmaceuticals ACAD:US $ 624.25M 75.87M
Agios Pharmaceuticals AGIO:US $ 1335.86M 101.88M
Amgen AMGN:US $ 59196M 1969M
Astellas Pharma 4503:JP Y 2332395M 23850M
Bayer BAYN:GR € 125782M 5541M
Biogen BIIB:US $ 23614.4M 262.9M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Celldex Therapeutics CLDX:US $ 424.04M 20.61M
Clovis Oncology CLVS:US $ 451.53M 21.3M
Daiichi Sankyo 4568:JP Y 2221402M 57930M
Eisai 4523:JP Y 1239315M 71959M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Esperion Therapeutics ESPR:US $ 342.85M 38.74M
Exelixis EXEL:US $ 2654.12M 37.88M
Genmab GEN:DC DK 24914M 287M
Gilead Sciences GILD:US $ 63080M 4872M
Glaxosmithkline GSK:US $ 89689M 10586M
GlaxoSmithKline GSK:LN 89689M 10586M
Immunogen IMGN:US $ 481.71M 44.06M
Insmed INSM:US $ 1.15B 90.19M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Merk MRK:US $ 106668M 974M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Moderna Inc MRNA:US 27.61B 2.94B
Novartis NOVN:VX SF 125218M 6577M
Puma Biotechnology PBYI:US $ 200.68M 25.9M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Seattle Genetics SGEN:US $ 3616.69M 102.91M
Spectrum Pharmaceuticals SPPI:US $ 100.05M 11.49M
Takeda 4502:JP Y 13178018M 479499M
Teva Pharmaceutical TEVA:IT 47.06B 607M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
Xencor XNCR:US $ 857.92M 19.71M
YTE INCY:US $ 5054.22M 120.87M